Diagnostyka (FRA:7JS) Other Operating Expense: €364.2 Mil (TTM As of Mar. 2026)


FRA:7JS Diagnostyka SA FRA:7JS
19 GF Score
Price €41.36
! 1 Warning Sign
View Full Analysis

What is Diagnostyka Other Operating Expense?

Diagnostyka FRA:7JS +1.17% 19 Other Operating Expense is €364.2 Mil as of Mar. 2026. GuruFocus rates FRA:7JS with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

Diagnostyka's Other Operating Expense for the three months ended in Mar. 2026 was €94.5 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €364.2 Mil.

Diagnostyka's quarterly Other Operating Expense increased from Sep. 2025 (€89.6 Mil) to Dec. 2025 (€95.6 Mil) but then declined from Dec. 2025 (€95.6 Mil) to Mar. 2026 (€94.5 Mil).

Diagnostyka's annual Other Operating Expense increased from Dec. 2023 (€185.1 Mil) to Dec. 2024 (€276.0 Mil) and increased from Dec. 2024 (€276.0 Mil) to Dec. 2025 (€352.0 Mil).

Diagnostyka Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Diagnostyka's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnostyka Other Operating Expense Chart

Diagnostyka Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
142.77 158.12 185.08 275.96 352.05

Diagnostyka Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.36 84.49 89.60 95.60 94.51
FRA:7JS
19GF Score
Diagnostyka SA FRA:7JS
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diagnostyka Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €364.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of €364.2 Mil mean?
Diagnostyka (FRA:7JS) has a Other Operating Expense of €364.2 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Diagnostyka and its competitors.
Is Diagnostyka's Other Operating Expense too high?
Diagnostyka's current Other Operating Expense is €364.2 Mil. Overall, Diagnostyka has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Diagnostyka's Other Operating Expense compare to TMO and DHR?
Diagnostyka's Other Operating Expense of €364.2 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Diagnostics & Research company?
A good Other Operating Expense depends on the Medical Diagnostics & Research industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Diagnostyka and its competitors. Diagnostyka's current Other Operating Expense is €364.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostyka stock overvalued right now?
Diagnostyka (FRA:7JS) has a current Other Operating Expense of €364.2 Mil. The current Other Operating Expense is €364.2 Mil. Diagnostyka's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Diagnostyka (FRA:7JS), the current Other Operating Expense is €364.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diagnostyka Business Description

Other Exchanges DIA:Poland
Address Ul. Prof. Michala Zyczkowskiego 16, Krakow, POL, 31-864
Diagnostyka SA is engaged in providing laboratory diagnostics services in Poland. The company offers comprehensive laboratory services from collecting biological material, through testing, to providing results online.
19GF Score

Get the complete analysis for FRA:7JS

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€41.36
Price